Resnick-Silverman L - Search Results

1

Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.

Mosoyan G, Nagi C, Marukian S, Teixeira A, Simonian A, Resnick-Silverman L, DiFeo A, Johnston D, Reynolds SR, Roses DF, Mosoian A. Mosoyan G, et al. Among authors: resnick silverman l. PLoS One. 2013;8(1):e55145. doi: 10.1371/journal.pone.0055145. Epub 2013 Jan 25. PLoS One. 2013. PMID: 23372829 Free PMC article.

2

Two Faces of SIVA.

Resnick-Silverman L, Manfredi JJ. Resnick-Silverman L, et al. Cancer Discov. 2015 Jun;5(6):581-3. doi: 10.1158/2159-8290.CD-15-0484. Cancer Discov. 2015. PMID: 26037915 Free PMC article.

3

Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy.

Resnick-Silverman L, Manfredi JJ. Resnick-Silverman L, et al. J Cell Biochem. 2006 Oct 15;99(3):679-89. doi: 10.1002/jcb.20925. J Cell Biochem. 2006. PMID: 16676359 Review.

4

Skp2B attenuates p53 function by inhibiting prohibitin.

Chander H, Halpern M, Resnick-Silverman L, Manfredi JJ, Germain D. Chander H, et al. EMBO Rep. 2010 Mar;11(3):220-5. doi: 10.1038/embor.2010.2. Epub 2010 Feb 5. EMBO Rep. 2010. PMID: 20134482 Free PMC article.

5

Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4.

Chander H, Halpern M, Resnick-Silverman L, Manfredi JJ, Germain D. Chander H, et al. PLoS One. 2011;6(8):e22456. doi: 10.1371/journal.pone.0022456. Epub 2011 Aug 4. PLoS One. 2011. PMID: 21829624 Free PMC article.

6

Analyzing p53 regulated DNA damage checkpoints by flow cytometry.

Resnick-Silverman L, Manfredi JJ. Resnick-Silverman L, et al. Methods Mol Biol. 2011;782:193-203. doi: 10.1007/978-1-61779-273-1_14. Methods Mol Biol. 2011. PMID: 21870293

7

A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction.

Monteith JA, Mellert H, Sammons MA, Kuswanto LA, Sykes SM, Resnick-Silverman L, Manfredi JJ, Berger SL, McMahon SB. Monteith JA, et al. Among authors: resnick silverman l. Mol Oncol. 2016 Oct;10(8):1207-20. doi: 10.1016/j.molonc.2016.05.007. Epub 2016 Jun 7. Mol Oncol. 2016. PMID: 27341992 Free PMC article.

8

p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.

Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N, Ozturk S, Saal LH, Su T, Cheung P, Schmidt H, Aaronson S, Hibshoosh H, Manfredi J, Rabadan R, Parsons R. Pappas K, et al. Among authors: resnick silverman l. Mol Cancer Res. 2017 Aug;15(8):1051-1062. doi: 10.1158/1541-7786.MCR-17-0089. Epub 2017 May 8. Mol Cancer Res. 2017. PMID: 28483946 Free PMC article.

9

Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase.

Giono LE, Resnick-Silverman L, Carvajal LA, St Clair S, Manfredi JJ. Giono LE, et al. Among authors: resnick silverman l. Oncogene. 2017 Dec 7;36(49):6762-6773. doi: 10.1038/onc.2017.254. Epub 2017 Aug 14. Oncogene. 2017. PMID: 28806397 Free PMC article.

10

p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints.

Lukin DJ, Carvajal LA, Liu WJ, Resnick-Silverman L, Manfredi JJ. Lukin DJ, et al. Among authors: resnick silverman l. Mol Cancer Res. 2015 Jan;13(1):16-28. doi: 10.1158/1541-7786.MCR-14-0177. Epub 2014 Aug 26. Mol Cancer Res. 2015. PMID: 25158956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page